News

Towards new OMP and paediatric Regulations 06-01-2021

 
Rare_Diseases_2_.png

ESIP feedback to the inception impact assessment on revision of OMP and paediatric legislation

In the framework of the new Pharmaceutical Strategy for Europe – released on 25 November – the European Commission published an Inception Impact Assessment (IIA) on the revision of Regulation No. 141/2000 on orphan and Regulation No. 1901/2006 on paediatric medicinal products.

Enabling healthy working lives 14-12-2020

 
Healthy_working_lives.jpg

ESIP feedback to the Green Paper on Ageing

ESIP shares the Commission’s opinion highlighted in its roadmap on the Green Paper on Ageing that the demographic change Europe faces requires a high-level policy debate on its long-term impact on social protection systems, especially care and pensions systems. To better evaluate the impact of ageing, the availability and comparability of data in the EU should be enhanced. In addition, the EU’s actions through the Green Paper on Ageing and possible follow-up initiatives should foster synergies with other EU strategies and policies and provide financing opportunities. 

 

Ensuring a high level of social protection 30-11-2020

 
EU_construction.jpg

ESIP puts forward its proposals for the implementation of the European Pillar of Social Rights

ESIP supported the goal of achieving renewed convergence towards a high level of social protection in its response to the public consultation on the European Pillar of Social Rights (EPSR). The reply is focused on the principles 9 to 18 of the EPSR, relevant to social security.

New Pharmaceutical Strategy for Europe 25-11-2020

 
Pharma_Strategy_EC_Schinas.jpg

Shaping future pharma policies for increased accessibility and affordability of medicines

On November 25 the European Commission released the new Pharmaceutical Strategy for Europe. The Strategy is intended as a roadmap for future action in the pharmaceutical sector, detailing a number of legislative and non-legislative initiatives for the coming years. Such actions should be deployed jointly with Member States.